至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Biglycan neo-epitope (BGN), a novel biomarker for screening early changes in equine osteoarthritic subchondral bone

Osteoarthritis Cartilage. 2022-07; 
S Adepu, S Ekman, J Leth, U Johansson, A Lindahl, E Skiöldebrand
Products/Services Used Details Operation
Proteins, Expression, Isolation and Analysis … (0.681 mg/ml, lot: U8229DL260-6, GenScript) was diluted in MultiBuffer to a concentration of 30 … This knowledge can enable us to prevent or stop OA development and progression at an … Get A Quote

摘要

objective: Native biglycan (BGN), which can undergo proteolytic cleavage in pathological conditions, is well known to be involved in bone formation and mineralization. This study aimed to delineate the specific cleavage fragment, a neo-epitope for BGN (BGN), in synovial fluid (SF) from young racehorses in training, osteoarthritic (OA) joints with subchondral bone sclerosis (SCBS), and chip fracture joints. design: A custom-made inhibition ELISA was developed to quantify BGN in SF. Cohort 1: A longitudinal study comprising 10 racehorses undergoing long-term training. Cohort 2: A cross-sectional study comprising joints from horses (N = 69) with different stages of OA and radiographically classified SCBS. Cohort... More

关键词

Biglycan neo-epitope, Chip fractures, Osteoarthritis, Race horses, Subchondral bone sclerosis